{"id":"alfarol-1-0-g","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypercalcemia"},{"rate":null,"effect":"Hyperphosphatemia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Weakness"}]},"_chembl":{"chemblId":"CHEMBL3648099","moleculeType":"Small molecule","molecularWeight":"400.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Alfarol (alfacalcidol) is a synthetic analog of calcitriol, the active form of vitamin D3. It binds to vitamin D receptors in target tissues, primarily in the intestine and bone, to enhance calcium absorption and regulate mineral metabolism. This mechanism makes it useful in treating conditions characterized by impaired vitamin D activation or mineral metabolism disorders.","oneSentence":"Alfarol is an active vitamin D analog that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:20:55.691Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypocalcemia and secondary hyperparathyroidism in chronic kidney disease"},{"name":"Hypoparathyroidism"},{"name":"Vitamin D-dependent rickets"},{"name":"Osteoporosis"}]},"trialDetails":[{"nctId":"NCT01430104","phase":"PHASE4","title":"A Study of Teriparatide in Japanese Osteoporosis Patients","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-08","conditions":"Osteoporosis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Alfarol 1.0 µg","genericName":"Alfarol 1.0 µg","companyName":"Eli Lilly and Company","companyId":"eli-lilly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Alfarol is an active vitamin D analog that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis. Used for Hypocalcemia and secondary hyperparathyroidism in chronic kidney disease, Hypoparathyroidism, Vitamin D-dependent rickets.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}